Immutep (IMMP) Operating Expenses (2015 - 2017)
Immutep (IMMP) posted Operating Expenses of $14.9 million for Q2 2017, up 736.63% on a QoQ basis from -$2.3 million in Q1 2017, and down 19.5% year-over-year from $18.5 million in Q2 2016.
Immutep (IMMP) Operating Expenses (2015 - 2017) Analysis & Trends
Immutep's Operating Expenses history runs 3 years deep, the most recent figure standing at $14.9 million for Q2 2017.
- Quarterly Operating Expenses fell 19.5% year-over-year to $14.9 million in Q2 2017, while the trailing twelve-month figure through Jun 2019 was $14.9 million (up 18.63% YoY) and the FY2025 annual result came in at $5.5 million, down 5.11% from the prior year.
- Operating Expenses was $14.9 million for Q2 2017 at Immutep, up from -$2.3 million in the prior quarter.
- Across five years, Operating Expenses topped out at $18.5 million in Q2 2016 and bottomed at -$6.2 billion in Q2 2015.
- A 3-year average of -$1.2 billion and a median of -$1.8 million in 2016 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2016 — Operating Expenses jumped 100.3% — and 2017, when it fell 29.98%.
- Immutep's Operating Expenses stood at -$6.2 billion in 2015, then soared by 100.3% to $18.5 million in 2016, then retreated by 19.5% to $14.9 million in 2017.
- Business Quant data shows IMMP's Operating Expenses at $14.9 million in Q2 2017, -$2.3 million in Q1 2017, and $18.5 million in Q2 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 14.86 Mn |
| Mar 31, 2017 | -2.33 Mn |
| Jun 30, 2016 | 18.46 Mn |
| Mar 31, 2016 | -1.80 Mn |
| Jun 30, 2015 | -6.16 Bn |